Opioids: cellular mechanisms of tolerance and physical dependence

Chris P Bailey1, Mark Connor

  • 1Department of Pharmacology, University of Bristol, School of Medical Sciences, Bristol BS8 1TD, UK. Chris.Bailey@bris.ac.uk

Insights

Understanding opioid tolerance and dependence is crucial. Research is exploring cellular mechanisms like receptor desensitization and protein changes, but a complete explanation for chronic opioid exposure remains a challenge.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Opioids, such as morphine, are widely used for pain relief but are also subject to abuse due to their analgesic and rewarding effects.
  • Development of tolerance and dependence (physical and psychological) occurs rapidly, within hours to weeks of opioid exposure.
  • The exact cellular and molecular mechanisms driving opioid tolerance and dependence are not fully understood.

Purpose of the Study:

  • To review and integrate current knowledge on the cellular mechanisms underlying opioid tolerance and dependence.
  • To highlight recent findings in mu-opioid receptor regulation, desensitization, and trafficking.
  • To identify gaps in understanding and propose future research directions for a comprehensive explanation of chronic opioid exposure effects.

Main Methods:

  • Review of recent scientific literature on opioid tolerance and dependence.
  • Analysis of studies investigating mu-opioid receptor (MOR) desensitization and trafficking.
  • Examination of research on protein expression changes during chronic opioid treatment and withdrawal.

Main Results:

  • Acute opioid receptor regulation involves desensitization and trafficking mechanisms.
  • Chronic opioid exposure leads to changes in various cellular proteins, potentially contributing to adaptation.
  • Multiple cellular processes are implicated, but their integration into a cohesive model is incomplete.

Conclusions:

  • While acute opioid receptor regulation is increasingly understood, the cellular basis of long-term opioid tolerance and dependence requires further investigation.
  • Integrating findings on receptor dynamics and protein alterations is key to explaining adaptations to chronic opioid exposure.
  • A comprehensive understanding necessitates bridging molecular-level findings with whole-animal observations in opioid-dependent subjects.

Related Concept Videos

Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...